Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Novartis (United States)

InstitutionResearch output, impact & collaborations

Novartis (United States) is a research organisation in New York, US. OpenAlex records 12,462 works and 1,792,652 citations for it. 2,896 researchers list it as their most recent affiliation.

12,462
Works
1,792,652
Citations
2,896
Researchers
37.1
Avg h-index

How has Novartis (United States)'s publication output changed over time?

ScholarIQpublication output · 1998–2019

Output grew0% over the shown period — from 2 works in 1998 to 2 in 2019.

2
1
1
1
2
2
1
2
19982003200520122014201720182019

Who are the most-cited researchers behind Novartis (United States)?

ScholarIQtop researchers by citations
1
Michael Rotte · Neural and Behavioral Psychology Studies
97 works7,828 citations
2
Randall Winnette · Hair Growth and Disorders
29 works459 citations

What are the most-cited papers on Novartis (United States)?

ScholarIQmost cited works
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker, Brendan M. Everett, Tom Thurén, Jean MacFadyen, William H. Chang, Christie M. Ballantyne, Francisco Antônio Helfenstein Fonseca, José Carlos Nicolau, Wolfgang Köenig, Stefan D. Anker, John J.P. Kastelein, Jan H. Cornel, Prem Pais, Daniel Pella, Jacques Genest, Renata Cífková, Alberto Lorenzatti, Tamás Forster, Zhanna Kobalava, L Vida-Simiti, Marcus Flather, Hiroaki Shimokawa, Hisao Ogawa, Mikael Dellborg, Paulo R.F. Rossi, Roland P.T. Troquay, Peter Libby, Robert J. Glynn
New England Journal of Medicine. 20179,298 CitationsOPEN ACCESS
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina, Giordano Caponigro, Nicolas Stransky, K. Venkatesan, Adam A. Margolin, Sung Joon Kim, Christopher J. Wilson, Joseph Lehár, Gregory V. Kryukov, Dmitriy Sonkin, Anupama Reddy, Manway Liu, Lauren Murray, Michael F. Berger, John E. Monahan, Paula Morais, Jodi Meltzer, Adam Korejwa, Judit Jané‐Valbuena, Felipa Mapa, Joseph Thibault, Eva Bric-Furlong, Pichai Raman, Aaron Shipway, Ingo H. Engels, Jill Cheng, Guoying Karen Yu, Jianjun Yu, Peter Aspesi, Melanie de Silva, Kalpana Jagtap, Michael D. Jones, Li Wang, Charlie Hatton, Emanuele Palescandolo, Supriya Gupta, Scott Mahan, Carrie Sougnez, Robert C. Onofrio, Ted Liefeld, Laura E. MacConaill, Wendy Winckler, Michael Reich, Nanxin Li, Jill P. Mesirov, Stacey Gabriel, Gad Getz, Kristin Ardlie, Vivien W. Chan, Vic E. Myer, Barbara L. Weber, Jeff Porter, Markus Warmuth, Peter M. Finan, Jennifer L. Harris, Matthew Meyerson, Todd R. Golub, Michael Morrissey, William R. Sellers, Robert Schlegel, Levi A. Garraway
Nature. 20128,591 Citations
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
John J.V. McMurray, Milton Packer, Akshay S. Desai, Jianjian Gong, Martin Lefkowitz, Adel R. Rizkala, Jean L. Rouleau, Victor Shi, Scott D. Solomon, Karl Swedberg, Michael R. Zile
New England Journal of Medicine. 20146,901 CitationsOPEN ACCESS
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Scott D. Solomon, John J.V. McMurray, Inder S. Anand, Junbo Ge, Carolyn S.P. Lam, Aldo P. Maggioni, Felipe A. Martínez, Milton Packer, Marc A. Pfeffer, Burkert Pieske, Margaret M. Redfield, Jean L. Rouleau, Dirk J. van Veldhuisen, Faı̈ez Zannad, Michael R. Zile, Akshay S. Desai, Brian Claggett, Pardeep S. Jhund, S. А. Boytsov, Josep Comín‐Colet, John G.F. Cleland, Hans‐Dirk Düngen, Eva Gonçalvesová, Tzvetana Katova, Jose F. Kerr Saraiva, Małgorzata Lelonek, Béla Merkely, Michele Senni, Sanjiv J. Shah, Jingmin Zhou, Adel R. Rizkala, Jianjian Gong, Victor Shi, Martin Lefkowitz
New England Journal of Medicine. 20192,383 CitationsOPEN ACCESS
Building Memories: Remembering and Forgetting of Verbal Experiences as Predicted by Brain Activity
Anthony D. Wagner, Daniel L. Schacter, Michael Rotte, Wilma Koutstaal, Anat Maril, Anders M. Dale, Bruce R. Rosen, Randy L. Buckner
Science. 19981,660 Citations

How much of the research on Novartis (United States) is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
8%
Bronze
58%
Closed
33%

Related on ScholarIQ

Chronic Myeloid Leukemia Treatments
Top Topic
Heart Failure Treatment and Management
Top Topic
Chronic Lymphocytic Leukemia Research
Top Topic
Spondyloarthritis Studies and Treatments
Top Topic
Asthma and respiratory diseases
Top Topic
Advanced Breast Cancer Therapies
Top Topic
470M+ articles · free account